BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine
BioNTech SE (Nasdaq: BNTX) today wants to express its thanks and gratitude not only to its employees but also to the many partners who have […]
Month: December 2020
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, […]
Spain – orders in vaccines
Spain, through the European Union, has signed contracts with seven companies, seven different vaccines, totalling 140 million doses, which would allow 80 million people to […]
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]
Vaccine roll-out to begin, thanks to the EU Strategy for COVID-19 vaccines
Sandra Gallina, Director General of the European Commission’s Directorate General for Health and Food Safety, talks about the imminent roll-out of COVID-19 vaccines. The EU […]
EMA important links on EU process for approval of Covid-19 vaccines
EMA held this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s […]
State aid: EU Commission gives green light to the Pan-European Guarantee Fund to enable up to €200 billion …
…financing for companies affected by the coronavirus outbreak in 21 Member States The European Commission found the creation of a €25 billion Pan-European Guarantee Fund […]
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial […]
U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization […]
Pfizer and BioNTech Vaccine to Prevent COVID-19 IMPORTANT SAFETY INFORMATION
Do not administer Pfizer‑BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer‑BioNTech COVID-19 […]
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately Pfizer Inc. (NYSE: PFE) and […]
EU and Member States Vaccine strategies and bestpractices – priority groups
The Commission has been working closely with Member States to define needs, explore strategies and to exchange information and best practices. In addition, modernising public […]
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory […]
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated […]
Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19
Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA […]